Is NVO stock a buy or a sell according to analysts?

Of the 39 analyst ratings on Novo Nordisk A/S, 59% are Buy or Strong Buy, 13 are Hold, and 3 are Sell. The overall consensus rating is Buy. Analyst ratings are opinions, not investment advice.

What is the analyst price target for NVO?

The average analyst price target for Novo Nordisk A/S is $42.33. Individual targets range from $40.00 to $47.00.

When is Novo Nordisk A/S's next earnings date?

Novo Nordisk A/S is scheduled to report earnings on November 4, 2026. Analysts expect earnings of $0.73 per share.

Does Novo Nordisk A/S pay a dividend?

Yes — Novo Nordisk A/S has paid $1.16 per share in dividends over the trailing twelve months.

How volatile is NVO stock?

NVO has a beta of 0.35, meaning it has historically been less volatile than the broader market.

What sector is Novo Nordisk A/S in?

Novo Nordisk A/S operates in the Healthcare sector, the Drug Manufacturers - General industry, and its stock trades on NYSE.

Back to Markets

Open NVO on Vela

Novo Nordisk A/S

NVO

0.00

USD

+0.00+0.00%

Overview Financials News Trades Technicals Forecast Transcripts

Novo Nordisk A/S at a glance

Open NVO on Vela

Novo Nordisk A/S (NVO) is a Healthcare company in the Drug Manufacturers - General industry, headquartered in Bagsvaerd, Denmark, with about 68,794 employees. Its shares trade on NYSE, and its IPO date is April 30, 1981. With a market capitalization of $172.6 billion, NVO is a large-cap stock.

It trades an average of 12.2 million shares a day.

In its latest reported quarter (results released August 5, 2026), Novo Nordisk A/S posted revenue of $12.1 billion and earnings of $0.96 per share, against estimates of $10.9 billion and $0.82.

Figures as of October 26, 2026, from market data providers. Descriptive only, not financial advice.

NVO, head to head

Comparisons

LLY vs NVOCompare NVO with LLY

NVO: Frequently asked questions

As of October 26, 2026, Novo Nordisk A/S has a market capitalization of $172.6 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.